Literature DB >> 6210107

Structure of an immunodominant epitope of the circumsporozoite surface protein of Plasmodium knowlesi.

D H Schlesinger, A H Cochrane, R W Gwadz, G N Godson, R Melton, R S Nussenzweig, V Nussenzweig.   

Abstract

Previous studies have shown that the immunodominant region of the circumsporozoite surface (CS) protein of Plasmodium knowlesi is contained within a tandemly repeated dodecapeptide: Gln-Ala-Gln-Gly-Asp-Gly-Ala-Asn-Ala-Gly-Gln-Pro. We show here that the CS protein epitopes reacting with six monoclonal antibodies raised against the intact parasite are represented in a synthetic tandem repeat of this dodecapeptide. The specificity of four of these antibodies was studied further by preparing synthetic peptides corresponding to overlapping regions of the repeats and measuring their ability to inhibit the specific interaction between the antibodies and CS proteins. We find that three antibodies have very similar patterns of reactivity with this series of peptides and that they define an epitope of eight amino acids (Gly-Asp-Gly-Ala-Asn-Ala-Gly-Gln) within the dodecapeptide. The remaining antibody probably recognizes a configurational epitope formed by a tandem repeat of the dodecapeptide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210107     DOI: 10.1021/bi00318a043

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Predicted conformations for the immunodominant region of the circumsporozoite protein of the human malaria parasite Plasmodium falciparum.

Authors:  K D Gibson; H A Scheraga
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 3.  Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.

Authors:  H G Heidrich
Journal:  Z Parasitenkd       Date:  1986

4.  Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.

Authors:  M E Jolivet; F M Audibert; H Gras-Masse; A L Tartar; D H Schlesinger; R Wirtz; L A Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

5.  Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.

Authors:  K Berzins; H Perlmann; B Wåhlin; J Carlsson; M Wahlgren; R Udomsangpetch; A Björkman; M E Patarroyo; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

6.  Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.

Authors:  G Del Giudice; A S Verdini; M Pinori; A Pessi; J P Verhave; C Tougne; B Ivanoff; P H Lambert; H D Engers
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

7.  Human-human hybridomas secreting monoclonal antibodies to the Mr 195,000 Plasmodium falciparum blood stage antigen.

Authors:  R Schmidt-Ullrich; J Brown; H Whittle; P S Lin
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

8.  Expression in yeast of a Plasmodium vivax antigen of potential use in a human malaria vaccine.

Authors:  P J Barr; H L Gibson; V Enea; D E Arnot; M R Hollingdale; V Nussenzweig
Journal:  J Exp Med       Date:  1987-04-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.